Funding for this research was provided by:
SPOR, Canadian Institutes of Health Research (383427)
Canadian HIV Trials Network, Canadian Institutes of Health Research (CTN283)
Merck Canada Inc. (IISP-53538)
Received: 13 October 2021
Accepted: 10 March 2022
First Online: 26 March 2022
: This web-based study was conducted as a part of the I-Score Study which obtained ethics approval from the Research Ethics Board (REB) of the McGill University Health Centre’s Research Institute in Montreal, Quebec, Canada (2015-2331/14-229 PSY), the site of participant inclusion, and the REB of the Nantes University Health Centre in Nantes, France (RC17_0310 N° EUDRACT: 2017-A02460-53).
: All participants consented to the use of their data for research purposes, including its publication, as specified in the consent form.
: The authors declare that they have no competing interests.